The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.

Mattias Aronsson; Håkan Walfridsson; Magnus Janzon; Ulla Walfridsson; Jens Cosedis Nielsen; Peter Steen Hansen; Arne Johannessen; Pekka Raatikainen; Gerhard Hindricks; Ole Kongstad Rasmussen; Steen Pehrson; Anders Englund; Juha Hartikainen; Leif Spange Mortensen; Lars-Åke Levin

doi:10.1093/europace/euu188

The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.

Mattias Aronsson, Håkan Walfridsson, Magnus Janzon, Ulla Walfridsson, Jens Cosedis Nielsen, Peter Steen Hansen, Arne Johannessen, Pekka Raatikainen, Gerhard Hindricks, Ole Kongstad Rasmussen, Steen Pehrson, Anders Englund, Juha Hartikainen, Leif Spange Mortensen, Lars-Åke Levin

Cardiology

Research output: Contribution to journal › Article › peer-review

Abstract

The aim of this prospective substudy was to estimate the cost-effectiveness of treating paroxysmal atrial fibrillation (AF) with radiofrequency catheter ablation (RFA) compared with antiarrhythmic drugs (AADs) as first-line treatment.

Original language	English
Pages (from-to)	48-55
Journal	Europace
Volume	17
Issue number	1
DOIs	https://doi.org/10.1093/europace/euu188
Publication status	Published - 2015

Subject classification (UKÄ)

Cardiology and Cardiovascular Disease

Access to Document

10.1093/europace/euu188

http://www.ncbi.nlm.nih.gov/pubmed/25341739?dopt=Abstract

Cite this

Aronsson, M., Walfridsson, H., Janzon, M., Walfridsson, U., Nielsen, J. C., Hansen, P. S., Johannessen, A., Raatikainen, P., Hindricks, G., Kongstad Rasmussen, O., Pehrson, S., Englund, A., Hartikainen, J., Mortensen, L. S., & Levin, L.-Å. (2015). The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy. Europace, 17(1), 48-55. https://doi.org/10.1093/europace/euu188

@article{b926d2cd54794316859b1c774911bc9f,

title = "The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.",

abstract = "The aim of this prospective substudy was to estimate the cost-effectiveness of treating paroxysmal atrial fibrillation (AF) with radiofrequency catheter ablation (RFA) compared with antiarrhythmic drugs (AADs) as first-line treatment.",

author = "Mattias Aronsson and H{\aa}kan Walfridsson and Magnus Janzon and Ulla Walfridsson and Nielsen, {Jens Cosedis} and Hansen, {Peter Steen} and Arne Johannessen and Pekka Raatikainen and Gerhard Hindricks and {Kongstad Rasmussen}, Ole and Steen Pehrson and Anders Englund and Juha Hartikainen and Mortensen, {Leif Spange} and Lars-{\AA}ke Levin",

year = "2015",

doi = "10.1093/europace/euu188",

language = "English",

volume = "17",

pages = "48--55",

journal = "Europace",

issn = "1532-2092",

publisher = "Oxford University Press",

number = "1",

}

Aronsson, M, Walfridsson, H, Janzon, M, Walfridsson, U, Nielsen, JC, Hansen, PS, Johannessen, A, Raatikainen, P, Hindricks, G, Kongstad Rasmussen, O, Pehrson, S, Englund, A, Hartikainen, J, Mortensen, LS & Levin, L-Å 2015, 'The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.', Europace, vol. 17, no. 1, pp. 48-55. https://doi.org/10.1093/europace/euu188

TY - JOUR

T1 - The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.

AU - Aronsson, Mattias

AU - Walfridsson, Håkan

AU - Janzon, Magnus

AU - Walfridsson, Ulla

AU - Nielsen, Jens Cosedis

AU - Hansen, Peter Steen

AU - Johannessen, Arne

AU - Raatikainen, Pekka

AU - Hindricks, Gerhard

AU - Kongstad Rasmussen, Ole

AU - Pehrson, Steen

AU - Englund, Anders

AU - Hartikainen, Juha

AU - Mortensen, Leif Spange

AU - Levin, Lars-Åke

PY - 2015

Y1 - 2015

N2 - The aim of this prospective substudy was to estimate the cost-effectiveness of treating paroxysmal atrial fibrillation (AF) with radiofrequency catheter ablation (RFA) compared with antiarrhythmic drugs (AADs) as first-line treatment.

AB - The aim of this prospective substudy was to estimate the cost-effectiveness of treating paroxysmal atrial fibrillation (AF) with radiofrequency catheter ablation (RFA) compared with antiarrhythmic drugs (AADs) as first-line treatment.

U2 - 10.1093/europace/euu188

DO - 10.1093/europace/euu188

M3 - Article

C2 - 25341739

SN - 1532-2092

VL - 17

SP - 48

EP - 55

JO - Europace

JF - Europace

IS - 1

ER -

The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this